ADGM
Adagio Medical Holdings, Inc.
+0.00 (+0.22%)0.50USD27.4K成交股數11.1M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00 | 0.00 | 0.00-100% | 0.00-100% | 0.00-100% | 0.00-100% | 132K+222% | 53K | 254K | 26K | 41K | – |
| 營業成本 | – | – | 58K | 31K | 342K | 253K | 414K | 157K | 682K | 542K | 253K | – |
| 毛利 | – | – | −58K-79% | −31K-70% | −342K-20% | −253K-51% | −282K+33% | −104K | −428K | −516K | −212K | – |
| 毛利率 | – | – | – | – | – | – | -213.6% | -196.2% | -168.5% | -1,984.6% | -517.1% | – |
| 研發費用 | 2.5M | 2.7M | 2.2M | 2.8M | 2.0M | 3.7M | 1.2M | 1.3M | 2.9M | 3.5M | 4.4M | – |
| 銷售管理費用 | 2.5M | 2.5M | 1.8M | 2.9M | 2.4M | 3.5M | 2.9M | 4.9M | 3.4M | 4.8M | 4.5M | – |
| 營業利益 | −4.9M+5% | −5.2M-30% | −4.1M-8% | −5.7M-8% | −4.7M-29% | −7.4M-16% | −4.4M-51% | −6.2M | −6.7M | −8.8M | −9.1M | – |
| 營業利益率 | – | – | – | – | – | – | -3,352.3% | -11,709.4% | -2,621.7% | -33,903.8% | -22,148.8% | – |
| 稅後淨利 | −6.7M+70% | −7.0M-9% | −3.3M-192% | −10.1M+23% | −3.9M-31% | −7.7M-4% | 3.6M-134% | −8.2M | −5.7M | −8.0M | −10.8M | – |
| 淨利率 | – | – | – | – | – | – | 2,731.8% | -15,537.7% | -2,257.5% | -30,838.5% | -26,246.3% | – |
| 稀釋 EPS | -0.30-14% | -0.31-39% | 0.01-50% | -0.66-92% | -0.35-95% | -0.51-95% | 0.02-100% | -8.34-41% | -7.35 | -10.28 | -14.15 | -14.15 |
| 稀釋股數 | 22.2M | 22.2M | 16.6M | 15.4M | 15.4M | 15.4M | 16.1M | 988K | 780K | – | – | 761K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 7.7M | 12.9M | 17.1M | 4.7M | 8.2M | 13.0M | 28.3M | 35.2M | 2.0M | 4.1M | 2.0M | – |
| 應收帳款 | – | – | – | – | – | 1K | 90K | – | – | – | – | – |
| 存貨 | 2.0M | 1.6M | 1.7M | 1.5M | 1.8M | 2.3M | 4.1M | – | – | – | – | – |
| 總資產 | 33.9M | 39.3M | 43.3M | 31.5M | 35.9M | 41.3M | 107M | – | – | – | – | – |
| 有息負債 | 24.8M | 22.9M | 21.0M | 21.2M | 16.9M | 17.7M | 13.8M | – | – | – | – | – |
| 總負債 | 34.3M | 33.6M | 30.9M | 32.9M | 27.2M | 28.9M | 30.6M | – | 5K | – | – | – |
| 股東權益 | −415K | 5.7M | 12.4M | −1.3M | 8.7M | 12.4M | 76.6M | −148M | −141M | −139M | −124M | – |
| 負債比 | 101.2% | 85.4% | 71.3% | 104.2% | 75.8% | 70.0% | 28.6% | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | −17.1M | −10.0M | −3.9M | −16.5M | −8.7M | −4.7M | 14.5M | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.1M-43% | – | – | – | −7.2M+7% | −6.4M | – | – | −6.7M | – | – |
| 資本支出 | – | 2K | – | – | – | 335K | 578K | – | – | 162K | – | – |
| 自由現金流 | – | −4.1M-45% | – | – | – | −7.5M+9% | −6.9M | – | – | −6.9M | – | – |
| 折舊攤銷 | – | 210K | – | – | – | 271K | 316K | – | – | 330K | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | -5,254.5% | – | – | -26,542.3% | – | – |
營收拆解 2023 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2023 年度 · 300K
| Single Reportable | 300K | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | – | −25.1M | –% | -1.51 | −19.4M |
| FY2024 | – | – | – | –% | – | – |
| FY2023 | 300K | – | −36.6M | -12,196.7% | -48.16 | −26.0M |